Severe Mitral Insufficiency Following Mitral Valvotomy

Original title: Acute Severe Mitral Regurgitation Following Balloon Mitral Valvulotomy: Echocardiographic Feature, Operative Finfing and Outcome in 50 Surgical Cases. Reference: Manjunath C. Nanjappa, et al. Catherization and Cardiovascular Intervention 81:603-608 (2013)

Severe Mitral Insufficiency Following Mitral Valvotomy (VPM) is a major complication; though not frequent, (0.9%-2%) it is life threatening and requires resolution through valve replacement.

The aim of this series was to analyze the evolution of patients with acute severe mitral insufficiency following VPM. 3855 patients undergoing VPM were analyzed, 50 patients (1.3%) presented ASMR after procedure and where referred to surgery. Wilkins score was ≤8 in 23 of those 50 patients. The most frequent signs of ASMR were hypotension and hypoxia followed by orthopnea and acute pulmonary edema.

The most frequent cause of severe MR was posterior mitral leaflet tear (36 patients), it was also observe a paracommisural tear with annular involvement (7 patients), posterior mitral leaflet tear (5 patients) and chordal tear (2ptes). The time from end of procedure to replacement surgery was between 3 and 96 hrs, and 6 patients died in this period (12%).

Patients were analyzed according to the moment of surgery and were divided in 2 groups: 24 hrs (11 patients). Both groups shared similar characteristics, mortality being significantly higher in the second group (1/39 vs 5/11, p<0.001).

Conclusion: 

Hypotension and hypoxia were the most common symptoms of Severe Mitral Insufficiency Following Mitral Valvotomy and posterior mitral leaflet tear was the most frequent cause. In this scenario, early valve replacement is most recommended.

Editorial comment: 

Mitral Valvotomy is a complex procedure that presents a low complications rate but these can be severe. Clinical, hemodynamic evaluation, with eco-Doppler is essential seeing that they not only help evaluate results, they also help diagnose complications and make the correct and timely decisions. 

Courtesy of Dr. Carlos Fava.
Interventional Cardiologist.
Favaloro Foundation. Argentina.

 

Dr. Carlos Fava para SOLACI.ORG

More articles by this author

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...

ACC 2026 | CHAMPION-AF: Left atrial appendage closure versus anticoagulation in atrial fibrillation

Can left atrial appendage closure challenge anticoagulation as the standard of care in atrial fibrillation? Atrial fibrillation (AF) is the most common sustained arrhythmia and...

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...